diabetics

Onglyza: New Diabetes Drug, Approved By The FDA

Filed in archive News , Treatment on August 2, 2009

Onglyza: New Diabetes Drug, Approved By The FDA
The US FDA has approved a new drug for the treatment of type 2 diabetes: ONGLYZA (saxagliptin)

Intended to be used with diet and exercise, Onglyza is a once-daily tablet that lowers high blood sugar levels.

Onglyza is a dipeptidyl peptidase-4 (DPP-4) inhibitor.

DPP-4 inhibitors affect the action of incretins, hormones that decrease elevated blood sugar levels (glucose) by increasing the body's utilisation of sugar, mainly through increasing insulin production in the pancreas and by reducing the liver's production of glucose.


Onglyza is a product of AstraZeneca.



Permalink: Onglyza: New Diabetes Drug, Approved By The FDA

Tags: ONGLYZA  (saxagliptin)  AstaZeneca  type  2  diabetes  smarty 

Vote for Onglyza: New Diabetes Drug, Approved By The FDA:

  • Currently 8.25/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 8.25 out of 4 vote(s) cast.
 
Share It
RSSrss
Google google
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
TwitterFollow us on Twitter!
Most Popular   Best of   Blogs, Blogging & Blogosphere   Challenges   Developments   Diabetics' Device   Did you know   Diet   Education   Exercise   Family Matters   Friends   Fun   Information   Information about   Inspiration   Interviews   Lifestyle   Misc   News   Notable